General Information of the Compound
| Compound ID |
CP0401242
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-[(2,4-dichlorophenyl)methyl]-1-[5-[4-(2,3-dichlorophenyl)piperazin-1-yl]pentyl]-5,5-dimethylimidazolidine-2,4-dione;hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H32Cl4N4O2
|
||||||||||||||||||
| Molecular Weight |
586.391
|
||||||||||||||||||
| Canonical SMILES |
CC1(C)N(CCCCCN2CCN(CC2)c2cccc(Cl)c2Cl)C(=O)N(Cc2ccc(Cl)cc2Cl)C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H32Cl4N4O2.ClH/c1-27(2)25(36)34(18-19-9-10-20(28)17-22(19)30)26(37)35(27)12-5-3-4-11-32-13-15-33(16-14-32)23-8-6-7-21(29)24(23)31;/h6-10,17H,3-5,11-16,18H2,1-2H3;1H
Show/Hide
|
||||||||||||||||||
| InChIKey |
WICBFQOIMPMYDE-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7